Eléments de l'association

	Cholestérol LDL	8
	Gilles Lambert	13
	Cholestérol LDL *Sauf* Gilles Lambert"	5
	Gilles Lambert *Sauf* Cholestérol LDL"	10
	Cholestérol LDL Et Gilles Lambert	3
	Cholestérol LDL Ou Gilles Lambert	18
	*Corpus*	11069

List of bibliographic references

Number of relevant bibliographic references: 3.

Ident.	Authors (with country if any)	Title
000699	Arjan J. Kwakernaak [Pays-Bas] ; Gilles Lambert [Australie, France] ; Maartje C. J. Slagman [Pays-Bas] ; Femke Waanders [Pays-Bas] ; Gozewijn D. Laverman [Pays-Bas] ; Francine Petrides [Australie] ; Bert D. Dikkeschei [Pays-Bas] ; Gerjan Navis [Pays-Bas] ; Robin P. F. Dullaart [Pays-Bas]	Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment
001713	Paul J. W. H. Kappelle [Pays-Bas] ; Gilles Lambert [Australie, France] ; Björn Dahlb Ck [Suède, Pays-Bas] ; Lars Bo Nielsen [Danemark] ; Robin P. F. Dullaart [Suède, Pays-Bas]	Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects
002F98	Gilles Lambert [Australie, France] ; Nicolas Ancellin [France] ; Francesca Charlton [Australie] ; Daniel Comas [France] ; Julia Pilot [France] ; Anthony Keech [Australie] ; Sanjay Patel [Australie] ; David R. Sullivan [Australie] ; Jeffrey S. Cohn [Australie] ; Kerry-Anne Rye [Australie] ; Philip J. Batter [Australie]	Plasma PCSK9 Concentrations Correlate with LDL and Total Cholesterol in Diabetic Patients and Are Decreased by Fenofibrate Treatment

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024